Baird Maintains Xylem(XYL.US) With Buy Rating, Cuts Target Price to $146
Stifel Maintains Xylem(XYL.US) With Buy Rating, Raises Target Price to $141
Xylem Is Maintained at Outperform by RBC Capital
RBC Capital Maintains Outperform on Xylem, Raises Price Target to $147
Xylem Is Maintained at Buy by Stifel
BNP Paribas Exane Adjusts Xylem's Price Target to $142 From $129
Citigroup Adjusts Xylem's Price Target to $137 From $134
Oppenheimer Adjusts Xylem's Price Target to $147 From $145
Stifel Adjusts Xylem's Price Target to $141 From $140
Goldman Sachs Adjusts Xylem's Price Target to $153 From $160
Xylem Is Maintained at Outperform by Baird
Xylem Analyst Ratings
Deutsche Bank Trims Price Target on Xylem to $133 From $136, Keeps Buy Rating
Baird Adjusts Price Target on Xylem to $146 From $149, Keeps Outperform Rating
Research Alert: Xyl: Q1 A Solid Start To The Year
Mizuho Securities Maintains Xylem(XYL.US) With Hold Rating, Announces Target Price $115
Oppenheimer Maintains Xylem(XYL.US) With Buy Rating, Cuts Target Price to $145
Stifel Maintains Xylem(XYL.US) With Buy Rating, Cuts Target Price to $140
RBC Capital Maintains Xylem(XYL.US) With Buy Rating, Raises Target Price to $143
Xylem Is Maintained at Buy by Stifel